Industry news

      2022 01.17
      Tigermed-Jyton Accelerates Approval of China’s First Full Magnetic Suspension Artificial Heart—New Hope for Patients with Advanced Heart Failure

      Recently, NationalMedical Products Administration (NMPA) approved the registrati···

      Home Prev 1 Next End
      Advance Human Health through
      Delivery Excellence
      Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

      Obtain the latest industry and regulatory updates on a monthly basis.

      I would like to receive Tigermed-Jyton's Regulatory Newsletter. Tigermed-Jyton guarantees that the above information will not be used for other purposes.

      Tel：+86-400-0739-391

      Email：consult@tigermedgrp.com

      Add：Suite 808,Union Plaza,Chaowai Street,Chaoyang District,Beijing

      China Postal Code：100020

      About us
      Service & Tech
      News
      Contact Us

      Copyright © 2017-2023 Tigermed-Jyton All Rights Reserved.

      TOP
      Contacts